MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Current Deferred Revenue came in at $1.8 million in Q4 2025, down 63.21% YoY from $4.8 million in Q4 2024, and down 35.23% on a QoQ basis from $2.7 million in Q3 2025.
MeiraGTx Holdings (MGTX) Current Deferred Revenue (2019 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 7 years of Current Deferred Revenue data on file, last reported at $1.8 million in Q4 2025.
- Quarterly Current Deferred Revenue fell 63.21% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 63.21% YoY) and the FY2025 annual result came in at $1.8 million, down 63.21% from the prior year.
- Current Deferred Revenue fell to $1.8 million in Q4 2025, from $2.7 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $25.6 million in Q1 2021 to a low of $1.8 million in Q4 2025.
- A 5-year average of $11.8 million and a median of $10.0 million in 2023 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue sank 80.65% — and 2024, when it jumped 64.97%.
- Tracing MGTX's Current Deferred Revenue over 5 years: stood at $21.8 million in 2021, then slumped by 30.69% to $15.1 million in 2022, then slumped by 80.65% to $2.9 million in 2023, then jumped by 64.97% to $4.8 million in 2024, then slumped by 63.21% to $1.8 million in 2025.
- The last three Current Deferred Revenue figures came in at $1.8 million (Q4 2025), $2.7 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MeiraGTx Holdings | 1.10 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.91 Mn |
| Mar 31, 2025 | 4.24 Mn |
| Dec 31, 2024 | 4.83 Mn |
| Sep 30, 2024 | 5.11 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 7.92 Mn |
| Jun 30, 2023 | 12.06 Mn |
| Mar 31, 2023 | 13.69 Mn |
| Dec 31, 2022 | 15.12 Mn |
| Sep 30, 2022 | 18.88 Mn |
| Jun 30, 2022 | 21.21 Mn |
| Mar 31, 2022 | 20.19 Mn |
| Dec 31, 2021 | 21.82 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 24.88 Mn |
| Mar 31, 2021 | 25.60 Mn |